Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Research probes interaction between SARS-CoV-2 and influenza

Researchers from Germany and France tried to determine if epidemiological studies based on co-detection prevalence data can offer a reliable estimation of interactions among respiratory viruses. They designed a simulation study by building on a general epidemiological model of co-circulation of 2 respiratory viruses that cause seasonal epidemics.

8 Sep 2021

New vaccinia-based COVID-19 vaccine candidate induces robust, durable immune responses

Researchers in Australia have developed a coronavirus disease 2019 (COVID-9) vaccine that induced robust and long-lived humoral and cellular immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in both young and aging mice.

8 Sep 2021

Study: Nearly one in five patients with malignant pleural mesothelioma contracted COVID-19

Nearly one in five patients with malignant pleural mesothelioma (MPM) at a Barcelona hospital contracted COVID-19 during the pandemic.

8 Sep 2021

Neuropsychiatric symptoms in children and adolescents with long COVID

In a recent study, researchers determine the presence of any neuropsychological symptoms after recovering from COVID-19 in children and adolescents.

8 Sep 2021

Infections during adolescence linked to increased risk of developing MS later in life

According to a new study, severe infections during adolescence may lead to an increased risk of contracting MS later in life. "We're talking mainly about brain and spinal cord infections, but also respiratory tract infections," says Scott Montgomery, professor at örebro University.

8 Sep 2021

Research reveals a new role for platelets in COVID-19 blood vessel damage

Abnormal crosstalk between blood platelets and cells lining blood vessels is one cause of deadly organ damage in patients with severe COVID-19, a new study finds.

8 Sep 2021

KA Imaging’s Reveal™ 35C Included in WHO Compendium

KA Imaging’s Reveal™ 35C has been included in the WHO's compendium of innovative health technologies for low-resource settings.

From KA Imaging 8 Sep 2021

Research highlights inequalities in England's COVID vaccine coverage

Researchers led by the epidemiologist Elise Tessier, of Public Health England, have been investigating the proportion of unvaccinated individuals against coronavirus disease 2019 (COVID-19) by age, sex, location, vaccine type, ethnicity and poverty level in the United Kingdom.

8 Sep 2021

Highly neutralizing human convalescent plasma reduces lung inflammation in SARS-CoV-2-infected macaques

A new study reignites the debate regarding the therapeutic utility of convalescent plasma in treating others with the COVID-19.

7 Sep 2021

A study of 105 protective and risk factors related to the incidence and severity of COVID-19

A recent study discusses both the known and unknown factors that may affect the risk of infection with SARS-CoV-2 and a severe course of COVID-19.

7 Sep 2021

Study could help improve design, fabrication, and use of nanofiber face masks

Since its outbreak, the COVID-19 virus has infected more than 207.7 million people worldwide and has claimed more than 4.3 million lives, according to the World Health Organization coronavirus dashboard as of Aug. 17.

7 Sep 2021

The pandemic almost killed Allie. Her community’s vaccination rate is 45%.

The Allie Henderson who stepped out of her mother's car to a driveway full of cheering friends and family holding "Welcome Home" signs was a wisp of her former self.

7 Sep 2021

High COVID-19 vaccine effectiveness in Israeli HCP

A study aimed to evaluate the VE against SARS-CoV-2 infection by carrying out a prospective cohort study that included healthcare personnel (HCP) in six hospitals in Israel.

7 Sep 2021

Emergency workers who attended the World Trade Center site early are at risk of developing COPD

Twenty years on from the September 11 attacks, rescue and recovery workers and volunteers who attended the World Trade Center site are beginning to develop chronic obstructive pulmonary disease (COPD) often following a previous diagnosis of asthma, according to research presented at the European Respiratory Society International Congress.

7 Sep 2021

COVID-19 infection does not appear to affect the lung function of young adults, finds study

COVID-19 infection does not appear to affect the lung function of young adults, according to new research presented at the 'virtual' European Respiratory Society International Congress today (Tuesday).

7 Sep 2021

Vesicular stomatitis virus-based COVID vaccines demonstrate potent antiviral efficacy against SARS-CoV-2 variants

Scientists from the National Institutes of Health, USA, have recently demonstrated the immunogenicity and protective efficacy of two vesicular stomatitis virus (VSV)-based coronavirus disease 2019 (COVID-19) vaccines in hamsters.

6 Sep 2021

Maternal SARS-CoV-2 vaccination in early-third trimester may optimize neonatal seroprotection

Researchers in Israel have conducted a study showing that vaccinating pregnant women against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) early on in the third trimester may maximize transplacental antibody transfer, potentially helping to prevent severe coronavirus disease 2019 (COVID-19) during infancy.

6 Sep 2021

Study reveals Pfizer/BioNTech and Oxford/AstraZeneca COVID-19 vaccine efficacy and immune response in clinically vulnerable individuals

The current study found that a strong S-antibody response occurs following complete vaccination with two different COVID-19 vaccines.

6 Sep 2021

Delta variant has a more diverse repertoire of mutations than other variants

In a paper, nearly 2 million SARS-CoV-2 genomes from around the world were analyzed, finding great diversity within the delta variant that exceeds that observed in the more widely spread alpha variant.

6 Sep 2021

Using infodemiology to understand symptoms of SARS-CoV-2 Lambda variant

A new variant (lineage C.37) initially identified in Lima, Peru, has since been classified as “Lambda” by the World Health Organization (WHO). The lambda variant was classified in June 2021 by the WHO as a “variant of interest.”

6 Sep 2021

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Research probes interaction between SARS-CoV-2 and influenza

New vaccinia-based COVID-19 vaccine candidate induces robust, durable immune responses

Study: Nearly one in five patients with malignant pleural mesothelioma contracted COVID-19

Neuropsychiatric symptoms in children and adolescents with long COVID

Infections during adolescence linked to increased risk of developing MS later in life

Research reveals a new role for platelets in COVID-19 blood vessel damage

KA Imaging’s Reveal™ 35C Included in WHO Compendium

Research highlights inequalities in England's COVID vaccine coverage

Highly neutralizing human convalescent plasma reduces lung inflammation in SARS-CoV-2-infected macaques

A study of 105 protective and risk factors related to the incidence and severity of COVID-19

Study could help improve design, fabrication, and use of nanofiber face masks

The pandemic almost killed Allie. Her community’s vaccination rate is 45%.

High COVID-19 vaccine effectiveness in Israeli HCP

Emergency workers who attended the World Trade Center site early are at risk of developing COPD

COVID-19 infection does not appear to affect the lung function of young adults, finds study

Vesicular stomatitis virus-based COVID vaccines demonstrate potent antiviral efficacy against SARS-CoV-2 variants

Maternal SARS-CoV-2 vaccination in early-third trimester may optimize neonatal seroprotection

Study reveals Pfizer/BioNTech and Oxford/AstraZeneca COVID-19 vaccine efficacy and immune response in clinically vulnerable individuals

Delta variant has a more diverse repertoire of mutations than other variants

Using infodemiology to understand symptoms of SARS-CoV-2 Lambda variant

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in